(Long Island, NY) Attorney General Eric T. Schneiderman released the following statement on today’s decision by the United States Court of Appeals for the Second Circuit, which affirmed the federal district court decision granting New York’s motion for a preliminary injunction against defendants Actavis plc and Forest Laboratories LLC.
“Today’s appeals court decision is a sweeping victory for consumers and Alzheimer’s patients. Our lawsuit and the court’s injunction protect competition and prevent Actavis from coercing Alzheimer’s patients into taking drugs they do not want in order to charge them monopoly prices. The litigation brought by my office sends a clear message: Drug companies cannot illegally prioritize profits over patients. My office will continue to protect New Yorkers from anticompetitive practices by drug manufacturers.”
